Comments
Loading...
Biotest Analyst Ratings and Price Targets | OTC:BIESF | Benzinga
Biotest Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Biotest Corp from these most-recent analyst ratings.
Analyst Ratings for Biotest
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Biotest (BIESF) stock?
There is no price target for Biotest
What is the most recent analyst rating for Biotest (BIESF)?
There is no analyst for Biotest
When was the last upgrade for Biotest (BIESF)?
There is no last upgrade for Biotest
When was the last downgrade for Biotest (BIESF)?
There is no last downgrade for Biotest.
When is the next analyst rating going to be posted or updated for Biotest (BIESF)?
There is no next analyst rating for Biotest.
Is the Analyst Rating Biotest (BIESF) correct?
There is no next analyst rating for Biotest.
Browse analyst ratings and price targets on all stocks.
